This research analyses the US Food and Drug Administration's (FDA's) risk methodology used for inspecting pharmaceutical manufacturing sites. It reviews the procedures, regulations, and violations specified in FDA warning letters (WLs). In particular it focuses on the time period between 2004-2009, as the FDA transitioned and formalised this new approach to site inspections. One of the principal outcomes of this study is to gauge the FDA's performance and assess its new methodology.

Most popular related searches

Related articles

Balancing water supply and demand—while addressing current and future vulnerabilities to extreme conditions such as drought—is essential to safeguarding the wellbeing of our communities.
Is your city at risk? Identifying where cities have problems and determining how much is at risk is the first step to becoming a strong, resilient city.
In states like California, water shortage is hardly a temporary problem, but there are very serious consequences that put local and state economies at risk. For...

We’re dealing with countless risks in our daily life, like getting cut during apple slicing, or catching cold if we get wet on a rainy day…or planning a project without a proper risk management plan…
Unknowingly you are doing Risk assessment in everyday life!
Take a rain (hazard) for instance… Before you leave home in the morning you turn on the news to determine if rain is likely or not. This is uncertainty. What are the chances that it will rain that day (likelihood), where (location)...

Humans can be exposed to hazardous air pollutants (HAPs) either directly through inhalation or indirectly through ingestion or dermal contact, which can result in acute or chronic health effects. The risk of exposure varies depending on a number of variables, including the meteorological conditions, local geographical and emissions characteristics, the age of the individuals being exposed, and the exposure duration and frequency. To evaluate and quantify the potential health impacts that may result from specific...

Multiphase partitioning of endocrine‐disrupting chemicals (EDCs) in the Pearl River (China) were investigated. The colloidal concentrations for 4‐tert‐octylphenol, 4‐nonylphenol, bisphenol A (BPA), and estrone (E1) were in the ranges of 0.2 ng/L to 0.8 ng/L, 23.2 ng/L to 108 ng/L, 2.3 ng/L to 97.6 ng/L, and not detectable (nd) to 0.32 ng/L, respectively; for truly dissolved concentrations, the ranges were 0.5 ng/L to 5.4 ng/L, 39 ng/L to 319 ng/L, 13.7 ng/L to 91.2 ng/L, and nd to 1.2 ng/L, respectively. Positive...

The goal of protecting the aquatic environment through testing thousands of chemicals against hundreds of aquatic species with thousands of endpoints while also considering mixtures is impossible given the present resources. Much of the impetus for studies on micropollutants, such as pharmaceuticals, came from the topic of endocrine disruption in wild fish. But despite concern over reductions in fish fertility, there is little evidence that fish populations are in peril. Indeed, fish biologists suggest that many...

Customer comments

No comments were found for Assessing FDA's risk methodology at pharmaceutical manufacturing sites. Be the first to comment!